Health
Antibiotice 1H Net Profit Rises 11% To RON25.7M
Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Thursday said its net profit rose 11.2% on the year to 25.75 million lei (EUR5.8 million) in the first half, helped by higher sale...
Pharmaceutical Market Slows Down In 2Q Because Of Focus On Profitability
The pharmaceutical market slowed down significantly in the second quarter of this year, down by 2.5% year-on-year in euros and up by 4.4% in lei, to EUR626 million (2.77 billion lei), shows...
Farmaceutica Remedia 1H Net Profit Up 14% To RON3.1M
Romanian pharmaceuticals wholesaler Farmaceutica Remedia Deva (RMAH.RO) Wednesday said its net profit rose 14% on the year to 3.13 million lei (EUR0.71 million) in the first six months, on h...
Terapia Ranbaxy Beats Rival Europharm To The Top Spot In 2011
Terapia Ranbaxy in Cluj became Romania’s largest drug maker last year, leaving rival Europharm behind by just EUR3 million. Terapia came close to EUR100 million in revenue and had the highes...
MedLife Turnover Up 26% In 1H To RON126M
Romanian private healthcare provider MedLife reported 126 million lei (EUR29 million) in turnover in the first half of the year, up 26% compared with the same interval in 2011.
Cepoi: Cantacuzino, Antibiotice Iasi And Unifarm To Merge Under A Sole Unit
Romanian Economy Minister Daniel Chitoiu Friday said the Health Ministry proposed that state-run drugmaker Antibiotice Iasi (ATB.RO) should invest in Cantacuzino Institute and further take o...
Private Healthcare Market Could Grow 60% In 3 Years To EUR800M In 2014
The Romanian medical services market, one of the most dynamic sectors in the last few years, could grow 8% this year and by as much as over 20% as of 2013 if certain regulations come into fo...
Doctors From Non-EU Countries May Be Allowed To Work In Romanian Healthcare
Doctors who are citizens of countries outside the European Union may be allowed to work in the Romanian healthcare system, under a bill drafted by the Health Ministry.
Terapia Ranbaxy’s Net Profit Up 28% In 2011, To EUR22.6M
Romanian pharmaceutical company Terapia Ranbaxy registered a net profit of 95.84 million lei (EUR22.6 million) in 2011, up 28 % on the year, and sales of RON421 million (EUR99.39 million), a...